Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Dogwood Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +4 vs. Q4 2025
- Shares held
- 3.62M
- +3.58M (+8,896.6%) vs. Q4 2025
- Total value
- $7.64M
- +$7.47M (+4,463.0%) vs. Q4 2025
- New holders
- 6
- 3 more added
- Sold out
- 2
- 0 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3,280,000 | $6.92M | 0.23% | +3,280,000 | New |
| Vanguard Capital Management LLC | 132,154 | $278.8K | 0.00% | +132,154 | New |
| Geode Capital Management, LLC | 79,434 | $167.6K | 0.00% | +62,655+373.4% | Added |
| Vanguard Fiduciary Trust Co | 62,736 | $132.4K | 0.00% | +62,736 | New |
| Northern Trust Corp | 23,779 | $50.2K | 0.00% | +23,779 | New |
| Goldman Sachs Group Inc | 14,598 | $30.8K | 0.00% | +14,598 | New |
| Marshall Wace, LLP | 11,756 | $24.8K | 0.00% | +101+0.9% | Added |
| Tower Research Capital LLC (TRC) | 8,067 | $17.0K | 0.00% | +8,067 | New |
| UBS Group AG | 7,085 | $14.9K | 0.00% | +5,337+305.3% | Added |
| Activest Wealth Management | 120 | $253 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 30 | $63 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 9 | $19 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 0 | $0 | 0.00% | −9,415−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −477−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |